Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001185185-24-000423
Filing Date
2024-04-24
Accepted
2024-04-24 12:03:56
Documents
17
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A novaccess20230930_10ka.htm   iXBRL 10-K/A 49644
2 EXHIBIT 31.1 ex_659180.htm EX-31.1 7540
3 EXHIBIT 31.2 ex_659181.htm EX-31.2 7729
4 EXHIBIT 32.1 ex_659182.htm EX-32.1 4192
  Complete submission text file 0001185185-24-000423.txt   279555

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20230930.xsd EX-101.SCH 3231
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20230930_def.xml EX-101.DEF 15845
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20230930_lab.xml EX-101.LAB 32339
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20230930_pre.xml EX-101.PRE 16781
20 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20230930_10ka_htm.xml XML 6273
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

EIN.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-29621 | Film No.: 24868209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)